News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Adnavance Technologies Inc. Appoints Biosite Incorporated (BSTE) Co-Founder Kenneth Buechler, Ph.D., to its Board of Directors


4/10/2008 8:47:39 AM

VANCOUVER, British Columbia & SAN DIEGO--(BUSINESS WIRE)--Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that it has appointed Kenneth Buechler, Ph.D., to its Board of Directors. Dr. Buechler was a co-founder of BioSite and served as the Company’s president until it was sold to Inverness for $1.9B last July.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES